Talphera, Inc. (TLPH) stock
TLPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.91−0.13 (-12.46%)
Close on Nov 13, 2026Market cap $47.03MP/E –Yield –
Talphera r&d expenses
Research and development expenses are spending on new products and technology.
Talphera's R&D Expenses for the twelve months ending Sep 30, 2026 was $7.09M, up 22.3% year over year. For fiscal 2025 it was $6.03M, down 10.2% from the year before. Over ten years it grew -12.3% a year on average. The highest annual figure on record is $26.29M in fiscal 2013.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.03M | -10.2% |
| FY2024 | Dec 31, 2024 | $6.72M | +21.1% |
| FY2023 | Dec 31, 2023 | $5.55M | +66.0% |
| FY2022 | Dec 31, 2022 | $3.34M | -18.4% |
| FY2021 | Dec 31, 2021 | $4.10M | +1.9% |
| FY2020 | Dec 31, 2020 | $4.02M | -13.8% |
| FY2019 | Dec 31, 2019 | $4.66M | -64.5% |
| FY2018 | Dec 31, 2018 | $13.14M | -32.3% |
| FY2017 | Dec 31, 2017 | $19.41M | -9.3% |
| FY2016 | Dec 31, 2016 | $21.40M | -4.8% |
| FY2015 | Dec 31, 2015 | $22.49M | -8.3% |
| FY2014 | Dec 31, 2014 | $24.52M | -6.7% |
| FY2013 | Dec 31, 2013 | $26.29M | +5.6% |
| FY2012 | Dec 31, 2012 | $24.91M | +82.8% |
| FY2011 | Dec 31, 2011 | $13.62M | +66.3% |
| FY2010 | Dec 31, 2010 | $8.19M | -47.1% |
| FY2009 | Dec 31, 2009 | $15.50M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.19M | +21.4% |
| Q2 FY2026 | Jun 30, 2026 | $1.69M | +12.7% |
| Q1 FY2026 | Mar 31, 2026 | $1.65M | +41.1% |
| Q4 FY2025 | Dec 31, 2025 | $1.56M | +18.0% |
| Q3 FY2025 | Sep 30, 2025 | $1.80M | -12.2% |
| Q2 FY2025 | Jun 30, 2025 | $1.50M | -21.4% |
| Q1 FY2025 | Mar 31, 2025 | $1.17M | -18.4% |
| Q4 FY2024 | Dec 31, 2024 | $1.32M | -25.2% |
| Q3 FY2024 | Sep 30, 2024 | $2.05M | +74.3% |
| Q2 FY2024 | Jun 30, 2024 | $1.91M | +23.0% |
| Q1 FY2024 | Mar 31, 2024 | $1.43M | +36.9% |
| Q4 FY2023 | Dec 31, 2023 | $1.77M | +189.1% |
| Q3 FY2023 | Sep 30, 2023 | $1.18M | +47.4% |
| Q2 FY2023 | Jun 30, 2023 | $1.55M | +41.9% |
| Q1 FY2023 | Mar 31, 2023 | $1.05M | +25.2% |
| Q4 FY2022 | Dec 31, 2022 | $612.00K | -37.9% |
| Q3 FY2022 | Sep 30, 2022 | $799.00K | -43.6% |
| Q2 FY2022 | Jun 30, 2022 | $1.09M | +51.1% |
| Q1 FY2022 | Mar 31, 2022 | $836.00K | -13.7% |
| Q4 FY2021 | Dec 31, 2021 | $986.00K | +17.9% |
| Q3 FY2021 | Sep 30, 2021 | $1.42M | +48.1% |
| Q2 FY2021 | Jun 30, 2021 | $724.00K | -10.9% |
| Q1 FY2021 | Mar 31, 2021 | $969.00K | -31.4% |
| Q4 FY2020 | Dec 31, 2020 | $836.00K | -21.4% |
| Q3 FY2020 | Sep 30, 2020 | $956.00K | -9.6% |
| Q2 FY2020 | Jun 30, 2020 | $813.00K | -30.1% |
| Q1 FY2020 | Mar 31, 2020 | $1.41M | +2.5% |
| Q4 FY2019 | Dec 31, 2019 | $1.06M | -60.7% |
| Q3 FY2019 | Sep 30, 2019 | $1.06M | -71.0% |
| Q2 FY2019 | Jun 30, 2019 | $1.16M | -64.5% |
| Q1 FY2019 | Mar 31, 2019 | $1.38M | -60.8% |
| Q4 FY2018 | Dec 31, 2018 | $2.70M | -26.4% |
| Q3 FY2018 | Sep 30, 2018 | $3.64M | -6.9% |
| Q2 FY2018 | Jun 30, 2018 | $3.28M | -33.1% |
| Q1 FY2018 | Mar 31, 2018 | $3.51M | -49.2% |
| Q4 FY2017 | Dec 31, 2017 | $3.68M | -42.0% |
| Q3 FY2017 | Sep 30, 2017 | $3.91M | – |
| Q2 FY2017 | Jun 30, 2017 | $4.90M | – |
| Q1 FY2017 | Mar 31, 2017 | $6.92M | – |
| Q4 FY2016 | Dec 31, 2016 | $6.33M | – |
See a number that looks wrong?